Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited
Your view on BJTRF
Overview
What the company does, where it operates, and who runs it.
About Beijing Tong Ren Tang Chinese Medicine Company Limited
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Wang Chi
- Headquarters
- Office Tower, Wan Chai, HK
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Wang Chi
- Headquarters
- Office Tower, Wan Chai, HK
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas.
It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Beijing Tong Ren Tang Chinese Medicine Company Limited, and the rating behind it. BJTRF last traded at $0.65, 10.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Beijing Tong Ren Tang Chinese Medicine Company Limited. Starting points for Beijing Tong Ren Tang Chinese Medicine Company Limited: P/E 10.6, EPS $0.55, beta 0.36 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Beijing Tong Ren Tang Chinese Medicine Company Limited. Beijing Tong Ren Tang Chinese Medicine Company Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Beijing Tong Ren Tang Chinese Medicine Company Limited. Trailing twelve-month EPS for Beijing Tong Ren Tang Chinese Medicine Company Limited stands at $0.55. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Beijing Tong Ren Tang Chinese Medicine Company Limited. Beijing Tong Ren Tang Chinese Medicine Company Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Beijing Tong Ren Tang Chinese Medicine Company Limited valued side by side against its closest peers. Beijing Tong Ren Tang Chinese Medicine Company Limited is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Beijing Tong Ren Tang Chinese Medicine Company Limited, and how their positions are changing. At a $542.8M market value, institutional positions materially move Beijing Tong Ren Tang Chinese Medicine Company Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Beijing Tong Ren Tang Chinese Medicine Company Limited executives and directors. Shares of Beijing Tong Ren Tang Chinese Medicine Company Limited have traded between $0.65 and $0.65 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Beijing Tong Ren Tang Chinese Medicine Company Limited. Beijing Tong Ren Tang Chinese Medicine Company Limited is a $542.8M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Beijing Tong Ren Tang Chinese Medicine Company Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Beijing Tong Ren Tang Chinese Medicine Company Limited. Coverage tracks Beijing Tong Ren Tang Chinese Medicine Company Limited within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.